Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
inflammatory5866 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A10827 | 31170503 | Biochim Biophys Acta Mol Cell Biol Lipids | Turnover of bile acids in liver, serum and caecal content by high-fat diet feeding affects hepatic steatosis in rats. | 2019 | Details |
| A10835 | 31165837 | Food Funct | Sinapine reduces non-alcoholic fatty liver disease in mice by modulating the composition of the gut microbiota. | 2019 | Details |
| A10840 | 31163617 | Int J Mol Sci | Exogenous Administration of Low-Dose Lipopolysaccharide Potentiates Liver Fibrosis in a Choline-Deficient l-Amino-Acid-Defined Diet-Induced Murine Steatohepatitis Model. | 2019 | Details |
| A10845 | 31161349 | Eur J Nutr | Moderate chronic ethanol consumption exerts beneficial effects on nonalcoholic fatty liver in mice fed a high-fat diet: possible role of higher formation of triglycerides enriched in monounsaturated fatty acids. | 2019 | Details |
| A10851 | 31156626 | Front Immunol | Chronic Liver Disease in Humans Causes Expansion and Differentiation of Liver Lymphatic Endothelial Cells. | 2019 | Details |
| A10859 | 31153588 | Acta Histochem | A histomorphometric study on the hepatoprotective effects of a green rooibos extract in a diet-induced obese rat model. | 2019 | Details |
| A10864 | 32953568 | J Tradit Complement Med | Calcium supplementation shows a hepatoprotective effect against high-fat diet by regulating oxidative-induced inflammatory response and lipogenesis activity in male rats. | 2019 | Details |
| A10868 | 31149745 | Aliment Pharmacol Ther | Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications. | 2019 | Details |
| A10871 | 31147590 | Sci Rep | Effects of açai on oxidative stress, ER stress, and inflammation-related parameters in mice with high fat diet-fed induced NAFLD. | 2019 | Details |
| A10901 | 31132798 | Horm Metab Res | Association Between Visfatin and Hepatic Steatosis in the General Population During Long-Term Follow-Up. | 2019 | Details |
| A10904 | 31132306 | Scand J Immunol | Epoxyeicosatrienoic acids alleviate methionine-choline-deficient diet-induced non-alcoholic steatohepatitis in mice. | 2019 | Details |
| A10911 | 31129048 | Biochem Pharmacol | A dual farnesoid X receptor/soluble epoxide hydrolase modulator treats non-alcoholic steatohepatitis in mice. | 2019 | Details |
| A10912 | 31128886 | J Pediatr | The Role of Genetic Predisposition, Programing During Fetal Life, Family Conditions, and Post-natal Diet in the Development of Pediatric Fatty Liver Disease. | 2019 | Details |
| A10916 | 31126557 | Complement Ther Med | Nigella sativa and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Results from a randomized, double-blind, placebo-controlled, clinical trial. | 2019 | Details |
| A10933 | 31114643 | World J Hepatol | Nonalcoholic fatty liver disease prevalence in an Italian cohort of patients with hidradenitis suppurativa: A multi-center retrospective analysis. | 2019 | Details |
| A10941 | 31113010 | Br J Pharmacol | Bouchardatine analogue alleviates non-alcoholic hepatic fatty liver disease/non-alcoholic steatohepatitis in high-fat fed mice by inhibiting ATP synthase activity. | 2019 | Details |
| A10946 | 31109939 | Diabetes | The cGAS-cGAMP-STING Pathway: A Molecular Link Between Immunity and Metabolism. | 2019 | Details |
| A10953 | 31105018 | Ann Hepatol | "Hepatic toxicity by methotrexate with weekly single doses associated with folic acid in rheumatoid and psoriatic arthritis. What is its real frequency?" | 2019 | Details |
| A10956 | 31104523 | Expert Rev Gastroenterol Hepatol | A critical appraisal of the use of ultrasound in hepatic steatosis. | 2019 | Details |
| A10957 | 31104052 | Obes Facts | SCCA-IgM as a Potential Biomarker of Non-Alcoholic Fatty Liver Disease in Patients with Obesity, Prediabetes and Diabetes Undergoing Sleeve Gastrectomy. | 2019 | Details |
| A10974 | 31096638 | Cells | Bone Morphogenetic Protein-8B Expression is Induced in Steatotic Hepatocytes and Promotes Hepatic Steatosis and Inflammation In Vitro. | 2019 | Details |
| A10976 | 31094472 | Ter Arkh | Biochemical and molecular-genetic indicators of inflammation and apoptosis in liver cirrhosis as an outcome of the progression of non-alcoholic steatohepatitis. | 2019 | Details |
| A10984 | 31092057 | Expert Rev Gastroenterol Hepatol | Association between non-alcoholic fatty liver disease and colorectal cancer. | 2019 | Details |
| A10986 | 31090267 | J Zhejiang Univ Sci B | Bile-ology: from bench to bedside. | 2019 | Details |
| A10987 | 31090041 | Curr Environ Health Rep | Understanding Environmental Contaminants' Direct Effects on Non-alcoholic Fatty Liver Disease Progression. | 2019 | Details |
| A10995 | 31087530 | Physiol Rep | Whole-body vibration for patients with nonalcoholic fatty liver disease: a 6-month prospective study. | 2019 | Details |
| A10998 | 31085647 | Proc Natl Acad Sci U S A | sGC stimulator praliciguat suppresses stellate cell fibrotic transformation and inhibits fibrosis and inflammation in models of NASH. | 2019 | Details |
| A11006 | 31083505 | Cells | Protective Effects of Licochalcone A Ameliorates Obesity and Non-Alcoholic Fatty Liver Disease Via Promotion of the Sirt-1/AMPK Pathway in Mice Fed a High-Fat Diet. | 2019 | Details |
| A11007 | 31083413 | Int J Mol Sci | Arazyme Suppresses Hepatic Steatosis and Steatohepatitis in Diet-Induced Non-Alcoholic Fatty Liver Disease-Like Mouse Model. | 2019 | Details |
| A11014 | 31081822 | J Vis Exp | An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes. | 2019 | Details |
| A11025 | 31078545 | Life Sci | Histological evaluation of nintedanib in non-alcoholic steatohepatitis mice. | 2019 | Details |
| A11027 | 31077838 | Clin Gastroenterol Hepatol | Daily Aspirin Use Associated With Reduced Risk For Fibrosis Progression In Patients With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11032 | 31076404 | Gut | Myeloid cells in liver and bone marrow acquire a functionally distinct inflammatory phenotype during obesity-related steatohepatitis. | 2019 | Details |
| A11048 | 31069057 | F1000Res | Recent advances in the understanding and management of polycystic ovary syndrome. | 2019 | Details |
| A11076 | 31055525 | Wiad Lek | The role of endothelial dysfunction in the progression mechanisms of non-alcoholic steatohepatitis in patients with obesity and chronic kidney disease. | 2019 | Details |
| A11087 | 31048208 | J Nutr Biochem | Metabolic dysfunction following weight regain compared to initial weight gain in a high-fat diet-induced obese mouse model. | 2019 | Details |
| A11101 | 31041786 | Semin Liver Dis | Macrophages as Key Players during Adipose Tissue-Liver Crosstalk in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11103 | 31040626 | Ann Gastroenterol | Prevalence of non-alcoholic fatty liver disease on computed tomography in patients with inflammatory bowel disease visiting an emergency department. | 2019 | Details |
| A11107 | 31039348 | Exp Cell Res | Epoxyeicosatrienoic intervention improves NAFLD in leptin receptor deficient mice by an increase in PGC1α-HO-1-PGC1α-mitochondrial signaling. | 2019 | Details |
| A11117 | 31034714 | Mol Nutr Food Res | Pear Extract and Malaxinic Acid Reverse Obesity, Adipose Tissue Inflammation, and Hepatosteatosis in Mice. | 2019 | Details |
| A11123 | 31032942 | J Cell Physiol | Cannabidiol protects livers against nonalcoholic steatohepatitis induced by high-fat high cholesterol diet via regulating NF-κB and NLRP3 inflammasome pathway. | 2019 | Details |
| A11132 | 31028903 | Pharmacol Res | Elafibranor restricts lipogenic and inflammatory responses in a human skin stem cell-derived model of NASH. | 2019 | Details |
| A11136 | 31026873 | Planta Med | Preventive Effects of Total Flavonoid C-Glycosides from Abrus mollis on Nonalcoholic Fatty Liver Disease through Activating the PPARα Signaling Pathway. | 2019 | Details |
| A11138 | 31026041 | Swiss Med Wkly | Controlled attenuation parameter for the assessment of liver steatosis in comparison with liver histology: a single-centre real life experience. | 2019 | Details |
| A11149 | 31022865 | Nutrients | Dietary Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA) Operate by Different Mechanisms to Modulate Hepatic Steatosis and Hyperinsulemia in fa/fa Zucker Rats. | 2019 | Details |
| A11168 | 31013163 | Endocr Pract | FATTY KIDNEY DISEASE: A NEW RENAL AND ENDOCRINE CLINICAL ENTITY? DESCRIBING THE ROLE OF THE KIDNEY IN OBESITY, METABOLIC SYNDROME, AND TYPE 2 DIABETES. | 2019 | Details |
| A11181 | 31009401 | Eur J Gastroenterol Hepatol | The promising role of probiotic and synbiotic therapy in aminotransferase levels and inflammatory markers in patients with nonalcoholic fatty liver disease - a systematic review and meta-analysis. | 2019 | Details |
| A11185 | 31008094 | Prev Nutr Food Sci | Long-Term Feeding of Soy Protein Attenuates Choline Deficient-Induced Adverse Effects in Wild Type Mice and Prohibitin 1 Deficient Mice Response More Sensitively. | 2019 | Details |
| A11195 | 31004566 | Biochem Pharmacol | Telmisartan and/or chlorogenic acid attenuates fructose-induced non-alcoholic fatty liver disease in rats: Implications of cross-talk between angiotensin, the sphingosine kinase/sphingoine-1-phosphate pathway, and TLR4 receptors. | 2019 | Details |
| A11196 | 31004178 | Arch Toxicol | A high-cholesterol diet promotes steatohepatitis and liver tumorigenesis in HCV core gene transgenic mice. | 2019 | Details |
| A11198 | 31003450 | Nutrients | Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation. | 2019 | Details |
| A11199 | 31002999 | Int Immunopharmacol | CXCR6 deficiency ameliorates ischemia-reperfusion injury by reducing the recruitment and cytokine production of hepatic NKT cells in a mouse model of non-alcoholic fatty liver disease. | 2019 | Details |
| A11207 | 30999670 | Cells | Therapeutic Application of Micellar Solubilized Xanthohumol in a Western-Type Diet-Induced Mouse Model of Obesity, Diabetes and Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A11209 | 30998190 | Ann Biol Clin (Paris) | [Incretins-adipocytokines interactions in type 2 diabetic subjects with or without non-alcoholic fatty liver disease: interest of GLP-1 (glucagon-like peptide-1) as a modulating biomarker]. | 2019 | Details |
| A11211 | 30995640 | Med Princ Pract | Serum Adropin Levels Are Reduced in Adult Patients with Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11239 | 30978348 | Life Sci | Periostin in chronic liver diseases: Current research and future perspectives. | 2019 | Details |
| A11265 | 30968772 | Curr Med Chem | Targeting n-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A11274 | 30964207 | Hepatology | MicroRNA-223 Ameliorates Nonalcoholic Steatohepatitis and Cancer by Targeting Multiple Inflammatory and Oncogenic Genes in Hepatocytes. | 2019 | Details |
| A11277 | 30962478 | Nat Commun | Hepatic arginase 2 (Arg2) is sufficient to convey the therapeutic metabolic effects of fasting. | 2019 | Details |
| A11286 | 30957185 | Mol Med Rep | Effects of daphnetin on lipid metabolism, insulin resistance and oxidative stress in OA‑treated HepG2 cells. | 2019 | Details |
| A11295 | 30951375 | FASEB J | The immunoregulatory effects of CD8 T-cell-derived perforin on diet-induced nonalcoholic steatohepatitis. | 2019 | Details |
| A11297 | 30950217 | J Cell Mol Med | Aucubin inhibited lipid accumulation and oxidative stress via Nrf2/HO-1 and AMPK signalling pathways. | 2019 | Details |
| A11311 | 30944821 | J Clin Transl Hepatol | Fatty Liver Disease and Gut Microbiota: A Comprehensive Update. | 2018 | Details |
| A11313 | 30943218 | PLoS One | Lipidomic and transcriptomic analysis of western diet-induced nonalcoholic steatohepatitis (NASH) in female Ldlr -/- mice. | 2019 | Details |
| A11316 | 30942432 | Int J Mol Med | Oxaliplatin aggravates hepatic oxidative stress, inflammation and fibrosis in a non‑alcoholic fatty liver disease mouse model. | 2019 | Details |
| A11319 | 30940296 | Gene Expr | Current and Emerging Approaches for Nonalcoholic Steatohepatitis Treatment. | 2019 | Details |
| A11320 | 30939889 | Rev Esp Enferm Dig | Psoriasis and fatty liver: a harmful synergy. | 2019 | Details |
| A11323 | 30937936 | J Cell Physiol | Morin reduces inflammatory responses and alleviates lipid accumulation in hepatocytes. | 2019 | Details |
| A11325 | 30937580 | Eur J Nutr | Erythrocyte membrane n-3 polyunsaturated fatty acids are inversely associated with the presence and progression of nonalcoholic fatty liver disease in Chinese adults: a prospective study. | 2019 | Details |
| A11327 | 30936549 | Nat Med | Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer. | 2019 | Details |
| A11331 | 30935688 | Biochem Biophys Res Commun | Metformin alleviates inflammatory response in non-alcoholic steatohepatitis by restraining signal transducer and activator of transcription 3-mediated autophagy inhibition in vitro and in vivo. | 2019 | Details |
| A11355 | 30924946 | Hepatology | Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps. | 2019 | Details |
| A11358 | 30923657 | PeerJ | Identification of key genes, pathways and potential therapeutic agents for liver fibrosis using an integrated bioinformatics analysis. | 2019 | Details |
| A11368 | 30920415 | Am J Gastroenterol | Angiotensin II Type 1 Receptor rs5186 Gene Variant Predicts Incident NAFLD and Associated Hypertension: Role of Dietary Fat-Induced Pro-Inflammatory Cell Activation. | 2019 | Details |
| A11377 | 30918952 | Inflamm Bowel Dis | Systematic Review With Meta-analysis: Epidemiology of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease. | 2019 | Details |
| A11392 | 30915409 | Clin Exp Hepatol | Allopurinol potentiates the hepatoprotective effect of metformin and vitamin E in fructose-induced fatty liver in rats. | 2019 | Details |
| A11394 | 30915401 | Clin Exp Hepatol | Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease. | 2019 | Details |
| A11395 | 30915371 | J Immunol Res | Immunoregulatory Effect of Koumine on Nonalcoholic Fatty Liver Disease Rats. | 2019 | Details |
| A11396 | 30914267 | J Hepatol | Macrophage p38α promotes nutritional steatohepatitis through M1 polarization. | 2019 | Details |
| A11400 | 30912307 | Physiol Rep | The long-term protective effects of neonatal administration of curcumin against nonalcoholic steatohepatitis in high-fructose-fed adolescent rats. | 2019 | Details |
| A11411 | 30905786 | Biochim Biophys Acta Mol Basis Dis | Chemokine (C-C motif) ligand 2 gene ablation protects low-density lipoprotein and paraoxonase-1 double deficient mice from liver injury, oxidative stress and inflammation. | 2019 | Details |
| A11414 | 30905208 | Expert Rev Gastroenterol Hepatol | Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in HIV infection: a metabolic approach of an infectious disease. | 2019 | Details |
| A11430 | 30897538 | Biomed Pharmacother | Biological mechanisms and related natural modulators of liver X receptor in nonalcoholic fatty liver disease. | 2019 | Details |
| A11443 | 30892882 | J Agric Food Chem | Preventive Efficiency of Green Tea and Its Components on Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11453 | 30888972 | Eur J Gastroenterol Hepatol | Neutrophil-to-lymphocyte ratio is independently associated with inflammatory activity and fibrosis grade in nonalcoholic fatty liver disease. | 2019 | Details |
| A11457 | 30888440 | Intensive Care Med | Obesity in the critically ill: a narrative review. | 2019 | Details |
| A11460 | 30887902 | Int J Vitam Nutr Res | Association of Pro-inflammatory Dietary Intake and Non-Alcoholic Fatty Liver Disease: Findings from Iranian case-control study. | 2019 | Details |
| A11461 | 30887659 | Int J Exp Pathol | Vitronectin deficiency attenuates hepatic fibrosis in a non-alcoholic steatohepatitis-induced mouse model. | 2019 | Details |
| A11464 | 30884843 | Cells | Ursodeoxycholic Acid Regulates Hepatic Energy Homeostasis and White Adipose Tissue Macrophages Polarization in Leptin-Deficiency Obese Mice. | 2019 | Details |
| A11480 | 30878016 | J Endocrinol | Short-term strength training reduces gluconeogenesis and NAFLD in obese mice. | 2019 | Details |
| A11483 | 30877020 | Pharmacol Ther | Intestinal microbiome as a novel therapeutic target for local and systemic inflammation. | 2019 | Details |
| A11497 | 30871035 | Nutrients | Eicosapentaenoic Acid Improves Hepatic Metabolism and Reduces Inflammation Independent of Obesity in High-Fat-Fed Mice and in HepG2 Cells. | 2019 | Details |
| A11516 | 30862046 | Int J Mol Sci | Metabolomics Characterizes the Effects and Mechanisms of Quercetin in Nonalcoholic Fatty Liver Disease Development. | 2019 | Details |
| A11523 | 30860608 | Lipids | Six-Week High-Fat Diet Alters the Gut Microbiome and Promotes Cecal Inflammation, Endotoxin Production, and Simple Steatosis without Obesity in Male Rats. | 2019 | Details |
| A11529 | 30855277 | J Clin Invest | Resolving inflammation in nonalcoholic steatohepatitis. | 2019 | Details |
| A11531 | 30854954 | Curr Pharm Biotechnol | Combined Amelioration of Ginsenoside (Rg1, Rb1, and Rg3)-enriched Korean Red Ginseng and Probiotic Lactobacillus on Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A11542 | 30850637 | Sci Rep | Connectivity mapping of angiotensin-PPAR interactions involved in the amelioration of non-alcoholic steatohepatitis by Telmisartan. | 2019 | Details |
| A11543 | 30850619 | Sci Rep | Voluntary exercise in mice fed an obesogenic diet alters the hepatic immune phenotype and improves metabolic parameters - an animal model of life style intervention in NAFLD. | 2019 | Details |
| A11557 | 30841472 | Biomed Pharmacother | Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue. | 2019 | Details |
| A11558 | 30841442 | Biomed Pharmacother | Genistein can ameliorate hepatic inflammatory reaction in nonalcoholic steatohepatitis rats. | 2019 | Details |